Status:
COMPLETED
Etoricoxib Versus Gabapentin for Knee Arthroscopy
Lead Sponsor:
Meir Medical Center
Conditions:
Knee Arthroscopy
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To determine that when administered as part of a multimodal analgesic regimen, use of the new COX-2 antagonist etoricoxib (120 mg/day, per os) is more effective in improving postoperative pain managem...
Detailed Description
Background: Post-discharge pain remains a significant problem after many ambulatory surgery procedures. Both etoricoxib and gabapentin have been used to prevent postoperative pain; however their relat...
Eligibility Criteria
Inclusion
- Elective ambulatory knee arthroscopy
Exclusion
- History of clinically-significant cardiovascular,pulmonary,hepatic,renal, neurologic, psychiatric or metabolic disease
- Patients chronically receiving pain killers
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00799149
Start Date
June 1 2006
End Date
May 1 2007
Last Update
November 27 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel, 44281